A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations
NCT01410747 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1484
Last updated 2024-10-22
Summary
To evaluate the safety and efficacy of tacrolimus for lupus nephritis under actual-use.
Conditions
Interventions
- DRUG
-
oral
Sponsors & Collaborators
-
Astellas Pharma Inc
lead INDUSTRY
Principal Investigators
-
Use Central Contact · Astellas Pharma Inc
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-04-10
- Primary Completion
- 2020-01-31
- Completion
- 2020-01-31
Countries
- Japan
Study Locations
More Related Trials
-
Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus Nephritis
NCT00615173 ·Status: COMPLETED ·Phase: PHASE3
-
Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis
NCT00125307 ·Status: COMPLETED ·Phase: PHASE4
-
Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis
NCT01207297 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Therapy in Lupus Nephropathy
NCT00001212 ·Status: COMPLETED ·Phase: PHASE2
-
Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis
NCT05207358 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Treatment in Refractory Lupus Nephritis
NCT01328834 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis
NCT01580865 ·Status: COMPLETED ·Phase: NA
-
Weaning of Immunosuppression in Nephritis of Lupus
NCT01284725 ·Status: COMPLETED ·Phase: PHASE3
-
Personalised Pharmacological Approach to the Tapering of Corticosteroid Doses in Systemic Lupus Patients Treated With Prednisone
NCT03187743 ·Status: COMPLETED ·Phase: NA
-
Long-Acting Tacrolimus for the Treatment of Resistant Lupus Nephritis
NCT01206569 ·Status: COMPLETED ·Phase: PHASE4
-
Low-dose Combination of Mycophenolate Mofetil (MMF) and Tacrolimus (Tac) for Refractory Lupus Nephritis
NCT01203709 ·Status: COMPLETED ·Phase: PHASE4
-
Comparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus Nephritis
NCT00371319 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy on Deoxyspergualin (NKT-01) in Patients With Lupus Nephritis
NCT00709722 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus Erythematosus
NCT05916781 ·Status: RECRUITING ·Phase: PHASE4
-
Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis
NCT00876616 ·Status: COMPLETED ·Phase: NA
-
Prospective Study of Rapamycin for the Treatment of SLE
NCT00779194 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis
NCT00404794 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Phase Treatment in Lupus Nephritis
NCT01288664 ·Status: WITHDRAWN ·Phase: PHASE3
-
Etanercept for the Treatment of Lupus Nephritis
NCT00447265 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Assess the Efficacy and Safety of FK506 Combined With Mycophenolate Mofetil (MMF) in Lupus Nephritis (III/IV/V)
NCT00298506 ·Status: COMPLETED ·Phase: NA
-
A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Nephritis
NCT01085097 ·Status: COMPLETED ·Phase: PHASE2
-
Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone
NCT00268567 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus
NCT01294774 ·Status: COMPLETED ·Phase: PHASE2
-
Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077)
NCT00094380 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis
NCT05138133 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3